"DERMATOLOGY, Reimagined. At Riverchase Dermatology and Cosmetic Surgery, delivering the best care simply isn’t enough. We go a step further by giving our patients the best experience. Our friendly staff and attentive providers are passionate about helping the most important person in the room—the patient. It is our mission to continue to grow in order to bring this commitment and dedication to reach as many patients as possible. Whether we are training our staff or sending pre-appointment communications, we keep the patient experience at the forefront and center everything around their experience as a whole. We have developed our practice strategically in several key areas to help advance this mission and vision."

During the past decade, Riverchase Dermatology and Cosmetic Surgery conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverchase Dermatology and Cosmetic Surgery" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Amgen" with 1 trials sponsored, "AnaptysBio, Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverchase Dermatology and Cosmetic Surgery" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Riverchase Dermatology and Cosmetic Surgery" are "Atopic Dermatitis" (4 trials), "Acne Inversa" (1 trials), "Palmoplantar Pustulosis" (1 trials), "Plaque Psoriasis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Riverchase Dermatology and Cosmetic Surgery" in a lesser frequency.

Most popular intervention types in "Riverchase Dermatology and Cosmetic Surgery" are "Drug" (7 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Baricitinib" (2 trials), "Lebrikizumab" (2 trials), "ABP 654" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Riverchase Dermatology and Cosmetic Surgery" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Riverchase Dermatology and Cosmetic Surgery". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Riverchase Dermatology and Cosmetic Surgery, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Riverchase Dermatology and Cosmetic Surgery, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".